HeartHero receives CE mark for automated external defibrillator device


HeartHero has announced that its automated external defibrillator (AED) device—known as Elliot—has received CE mark approval. In a press release, the company said that its goal for the device to become the lowest-cost, easiest-to-use, and most portable AED on the market.

HeartHero founder and CEO Gary Montague, said: “Currently there are 86 million people with Cardiac Risk Factors, 12 million of those are high-risk for Cardiac Arrest in the United States alone. It is time that we address those at risk and empower them with a device.”

In February 2020, HeartHero partnered with the American College of Cardiology (ACC), in an alliance that the two organisations said would aim to make a “significant impact” on survival rates after sudden cardiac arrest (SCA).

John Rumsfeld, chief innovation officer at the American College of Cardiology (ACC), said: “There’s a lot of technology out there, but not a lot where you can draw a direct line between a new technology and potentially saving a life. HeartHero’s AED is one of them.”

Following the CE mark approval, HeartHero anticipates that the device will be available for pre-order in Europe in the coming months and is progressing towards the US Food and Drug Administration (FDA) approval process in the USA.


Please enter your comment!
Please enter your name here